Prednisone

Prednisone is a synthetic corticosteroid medication that is commonly prescribed for various medical conditions. It is a potent anti-inflammatory and immunosuppressant drug. Here is some information about prednisone:

Treatment of Inflammatory Conditions

Prednisone is often prescribed to reduce inflammation in various medical conditions, including allergic reactions, asthma, rheumatoid arthritis, lupus, and inflammatory bowel disease. It helps to suppress the body’s immune response, thereby alleviating symptoms such as swelling, pain, redness, and allergic reactions.

Dosage and Duration of Treatment

The dosage of prednisone and the duration of treatment will vary depending on the specific condition being treated, its severity, and the individual’s response to the medication. Prednisone is available in various forms, including tablets, oral solution, and injections. It is usually taken once daily, with or after food. It is important to follow the prescribed dosage and instructions provided by the doctor.

Potential Side Effects and Precautions

Prednisone can have numerous side effects, especially when used for a prolonged period or at high doses. Common side effects may include increased appetite, weight gain, fluid retention, mood changes, difficulty sleeping, and increased susceptibility to infections. Long-term use of prednisone can lead to more serious side effects, such as osteoporosis, high blood pressure, diabetes, and adrenal suppression.

It is important to follow the healthcare professional’s instructions and to gradually taper off the medication when discontinuing its use, as sudden withdrawal can lead to adrenal insufficiency.

Prednisone should be used with caution in individuals with certain medical conditions, including diabetes, high blood pressure, osteoporosis, or a history of gastric ulcers. It may interact with other medications, so it is important to inform your healthcare professional about all the medications you are currently taking.

Can I obtain prednisone without a prescription?

No, it is not possible to obtain prednisone without a prescription.

Prednisone is a prescription medication that belongs to the class of corticosteroids. It is a potent medication that can have significant side effects and should only be used under the guidance of a healthcare professional. Buy prednisone without a prescription is illegal and potentially dangerous. It is important to consult with a qualified healthcare provider who can evaluate your condition, determine if prednisone is appropriate for your specific needs, and prescribe the medication if necessary.

Regular Monitoring and Consultation

Prednisone is a prescription medication, and its use should be supervised by a healthcare professional. Regular follow-up visits and discussions with your doctor are important to monitor the effectiveness of the medication, adjust the dosage if needed, and assess any potential side effects.

WARNING: It is crucial to consult with a healthcare professional or doctor for personalized advice and guidance regarding the use of prednisone or any other corticosteroid medication. They will be able to provide specific instructions based on your medical history, individual needs, and the condition being treated.

References

1. ^ Pickup ME (1979). “Clinical pharmacokinetics of prednisone and prednisolone”. Clinical Pharmacokinetics. 4 (2): 111–128. doi:10.2165/00003088-197904020-00004. PMID 378499. S2CID 12218704.
2. ^ Jump up to:^{a b c d e f g h i} “Prednisone Monograph for Professionals”. Drugs.com. AHFS. Retrieved 24 December 2018.
3. ^ Jump up to:^a b Brunton L (2017). Goodman & Gilman’s the pharmacological basis of therapeutics (13 ed.). McGraw-Hill Education. pp. 739, 746, 1237. ISBN 978-1-25-958473-2.
4. ^ “Prednisone Use During Pregnancy”. Drugs.com. Retrieved 24 December 2018.
5. ^ “Product Information Panafcort (prednisone) Panafcortelone (prednisolone)” (PDF). TGA eBusiness Services. St Leonards, Australia: Aspen Pharmacare Australia Pty Ltd. 11 July 2017. pp. 1–2. Retrieved 30 June 2018.
6. ^ Buttgereit F, Gibofsky A (June 2013). “Delayed-release prednisone – a new approach to an old therapy”. Expert Opinion on Pharmacotherapy. 14 (8): 1097–1106. doi:10.1517/14656566.2013.782001. PMID 23594208. S2CID 22720230.
7. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 485. ISBN 9783527607495.
8. ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
9. ^ “The Top 300 of 2020”. ClinCalc. Retrieved 7 October 2022.
10. ^ “Prednisone – Drug Usage Statistics”. ClinCalc. Retrieved 7 October 2022.
11. ^ Autoimmune Hepatitis~treatment at eMedicine
12. ^ “Corticosteroids”. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. NCBI Bookshelf. 30 May 2014. PMID 31643719. NBK548400. Retrieved 19 March 2020.
13. ^ “Prednisone”. The American Society of Health-System Pharmacists. Retrieved 3 April 2011.
14. ^ Wackym PA, Snow JB (2017). Ballenger’s Otorhinolaryngology: Head and Neck Surgery. PMPH USA. p. 1185. ISBN 9781607951773.
15. ^ “Antineoplastic Agents, Hormonal”. Medical Subject Headings. U.S. National Library of Medicine. 2009. Retrieved 11 November 2010.
16. ^ “Steroid Treatments Equally Effective Against Sudden Deafness”. National Institutes of Health (NIH). 22 May 2015. Retrieved 9 May 2022.
17. ^ Riemer AD (April 1958). “Application of the newer corticosteroids to augment diuresis in congestive heart failure”. The American Journal of Cardiology. 1 (4): 488–496. doi:10.1016/0002-9149(58)90120-6. PMID 13520608.
18. ^ Newman DA (February 1959). “Reversal of intractable cardiac edema with prednisone”. New York State Journal of Medicine. 59 (4): 625–633. PMID 13632954.
19. ^ Zhang H, Liu C, Ji Z, Liu G, Zhao Q, Ao YG, et al. (September 2008). “Prednisone adding to usual care treatment for refractory decompensated congestive heart failure”. International Heart Journal. 49 (5): 587–595. doi:10.1536/ihj.49.587. PMID 18971570.
20. ^ Liu C, Liu G, Zhou C, Ji Z, Zhen Y, Liu K (September 2007). “Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance”. The Canadian Journal of Cardiology. 23 (11): 865–868. doi:10.1016/s0828-282x(07)70840-1. PMC 2651362. PMID 17876376.
21. ^ Liu C, Chen H, Zhou C, Ji Z, Liu G, Gao Y, et al. (October 2006). “Potent potentiating diuretic effects of prednisone in congestive heart failure”. Journal of Cardiovascular Pharmacology. 48 (4): 173–176. doi:10.1097/01.fjc.0000245242.57088.5b. PMID 17086096. S2CID 45800521.
22. ^ Massari F, Mastropasqua F, Iacoviello M, Nuzzolese V, Torres D, Parrinello G (March 2012). “The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?”. The American Journal of Emergency Medicine. 30 (3): 517.e5–517.10. doi:10.1016/j.ajem.2011.01.023. PMID 21406321.
23. ^ Liu C, Chen Y, Kang Y, Ni Z, Xiu H, Guan J, Liu K (October 2011). “Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure”. The Journal of Pharmacology and Experimental Therapeutics. 339 (1): 203–209. doi:10.1124/jpet.111.184796. PMID 21737535. S2CID 1892149.
24. ^ Jump up to:^a b c “Prednisone and other corticosteroids: Balance the risks and benefits”. Mayo Clinic. Retrieved 7 April 2017.
25. ^ “Prednisone Information”. Drugs.com.
26. ^ “Prednisone”. MedlinePlus Drug Information.
27. ^ Wolkowitz OM, Lupien SJ, Bigler ED (June 2007). “The “steroid dementia syndrome”: a possible model of human glucocorticoid neurotoxicity”. Neurocase. 13 (3): 189–200. doi:10.1080/13554790701475468. PMID 17786779. S2CID 39340010.
28. ^ “Steroids”. Australian Department of Health & Human Services. April 2016. Retrieved 14 June 2018.
29. ^ “Polymyalgia rheumatica: treatment reviews are needed”. NIHR Evidence. 21 June 2022. doi:10.3310/nihrevidence_51304. S2CID 251774691. Retrieved 5 August 2022.
30. ^ Sokhal BS, Hider SL, Paskins Z, Mallen CD, Muller S (2021). “Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study”. Rheumatology Advances in Practice. 5 (3): rkab094. doi:10.1093/rap/rkab094. PMC 8712242. PMID 34988356.
31. ^ Miller NR, Walsh FB, Hoyt WF (2005). Walsh and Hoyt’s Clinical Neuro-ophthalmology. Lippincott Williams & Wilkins. p. 1062. ISBN 9780781748117.
32. ^ “The Prednisone Tinnitus Connection”. Tinnitus and You. 12 June 2021. Retrieved 9 May 2022.
33. ^ Schakman O, Gilson H, Kalista S, Thissen JP (November 2009). “Mechanisms of muscle atrophy induced by glucocorticoids”. Hormone Research. 72 (Suppl 1): 36–41. doi:10.1159/000229762. PMID 19940494. S2CID 21997662.
34. ^ “Steroid Drug Withdrawal Symptoms, Treatment & Prognosis”. MedicineNet. Retrieved 14 June 2018.
35. ^ Bello CS, Garrett SD. “Therapeutic and Adverse Effects of Glucocorticoids”. U.S. Pharmacist Continuing Education Program. Archived from the original on 11 July 2008.
36. ^ Iliopoulou A, Abbas A, Murray R (19 May 2013). “How to manage withdrawal of glucocorticoid therapy”. Prescriber. 24 (10): 23–29. doi:10.1002/psb.1060. S2CID 72082017.
37. ^ Becker DE (Spring 2013). “Basic and clinical pharmacology of glucocorticosteroids”. Anesthesia Progress. 60 (1): 25–31, quiz 32. doi:10.2344/0003-3006-60.1.25. PMC 3601727. PMID 23506281.
38. ^ Jump up to:^a b “Prednisone”. DrugBank. Retrieved 29 January 2019.
39. ^ “Prednisone”. MedlinePlus. NIH U.S. National Library of Medicine.
40. ^ Jump up to:^a b Schijvens AM, Ter Heine R, de Wildt SN, Schreuder MF (March 2019). “Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome”. Pediatric Nephrology. 34 (3): 389–403. doi:10.1007/s00467-018-3929-z. PMC 6349812. PMID 29549463.
41. ^ Wan Y (8 January 2009). “Delayed-release prednisone (Lodotra™) approved in EU for treatment of rheumatoid arthritis”. Archived from the original on 9 July 2009. Retrieved 22 November 2009.
42. ^ Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. (January 2008). “Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial”. Lancet. 371 (9608): 205–214. doi:10.1016/S0140-6736(08)60132-4. PMID 18207016. S2CID 6197980.
43. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1013–. ISBN 978-1-4757-2085-3.
44. ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 871–. ISBN 978-3-88763-075-1.
45. ^ Wainwright M (1998). “The secret of success: Arthur Nobile’s discovery of the steroids prednisone and prednisolone in the 1950s revolutionised the treatment of arthritis”. Chemistry in Britain. 34 (1): 46. OCLC 106716069.
46. ^ “Inventor Profile: Arthur Nobile”. National Inventors Hall of Fame. Archived from the original on 12 June 2012.
47. ^ “Arthur Nobile”. New Jersey Inventors Hall of Fame. Archived from the original on 1 September 2011.
48. ^ Merck Index (14th ed.). Merck & Co. Inc. 2006. p. 1327. ISBN 978-0-911910-00-1.
49. ^ Jump up to:^a b Herzog HL, Nobile A, Tolksdorf S, Charney W, Hershberg EB, Perlman PL (February 1955). “New antiarthritic steroids”. Science. 121 (3136): 176. Bibcode:1955Sci…121..176H. doi:10.1126/science.121.3136.176. PMID 13225767.
50. ^ “Meticorten: FDA-Approved Drugs”. U.S. Food and Drug Administration (FDA).
51. ^ “Delta-Cortef: FDA-Approved Drugs”. U.S. Food and Drug Administration (FDA).